Prosthetic valve endocarditis due to Candida albicans treated successfully with medical treatment alone

The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi
Manabu NoguchiSunao Atogami

Abstract

Prosthetic valve endocarditis (PVE) caused by Candida species is associated with high morbidity and mortality. A combination of surgical resection and antifungal drug therapy is the golden standard for treatment, yet surgical intervention is not possible in all cases of Candida PVE. We report a case of PVE due to Candida albicans cured by medical treatment alone. This case suggests that, in some instances, Candida PVE can be managed medically with antifungal therapy. Such a conservative approach should be applied with caution and necessitates very close follow-up on a long-term basis.

References

Jul 1, 1982·Progress in Cardiovascular Diseases·K H Mayer, S C Schoenbaum
Feb 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M H NguyenM Amidi
Feb 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H M GilbertB J Hartman
Jan 1, 1996·Infection·H Hogevik, K Alestig
Aug 15, 2001·Diagnostic Microbiology and Infectious Disease·J D LiangK T Luh
Jan 10, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Junya AkoYasuyoshi Ouchi

❮ Previous
Next ❯

Citations

Mar 15, 2005·Scandinavian Journal of Infectious Diseases·Marco BongiovanniTeresa Bini
Jul 10, 2019·Circulation Journal : Official Journal of the Japanese Circulation Society·Satoshi NakataniUNKNOWN Japanese Circulation Society Joint Working Group
Oct 28, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Claire RivoisyUNKNOWN French Mycoses Study Group and Grupo de Apoyo al Manejo de las Endocarditis en España (GAMES)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

JAMA : the Journal of the American Medical Association
Andrew WangInternational Collaboration on Endocarditis-Prospective Cohort Study Investigators
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
M H NguyenM Amidi
La Tunisie médicale
Skander Ben OmraneAdel Khayati
JAMA Internal Medicine
Tahaniyat LalaniInternational Collaboration on Endocarditis–Prospective Cohort Study Investigators
© 2022 Meta ULC. All rights reserved